Pauciullo A, Versace C, Gaspa G, Letaief N, Bedhiaf-Romdhani S, Fulgione A
Animals (Basel). 2023; 13(17).
PMID: 37685069
PMC: 10487017.
DOI: 10.3390/ani13172805.
Afonso G, Cavaleiro C, Valero J, Mota S, Ferreiro E
Cells. 2023; 12(13).
PMID: 37443797
PMC: 10340215.
DOI: 10.3390/cells12131763.
Li A, Xiao H, Zhao Z, Xiang C, Chen Z, Wang P
J Cancer Res Clin Oncol. 2023; 149(11):9105-9128.
PMID: 37171615
DOI: 10.1007/s00432-023-04849-1.
Ranapour S, Motamed N
Mol Biotechnol. 2023; 65(12):1979-1990.
PMID: 36905464
DOI: 10.1007/s12033-023-00702-5.
Cultrera G, Giudice A, Santonocito S, Ronsivalle V, Conforte C, Reitano G
Int J Mol Sci. 2022; 23(24).
PMID: 36555142
PMC: 9779831.
DOI: 10.3390/ijms232415501.
Small extracellular vesicle-associated miR-6068 promotes aggressive phenotypes of prostate cancer through miR-6068/HIC2/SIRT1 axis.
Gaballah M, Ali H, A Hassan Z, Mahgoub S, Ali H, Rhim J
Am J Cancer Res. 2022; 12(8):4015-4027.
PMID: 36119841
PMC: 9442005.
Screening and Biological Function Analysis of miRNA and mRNA Related to Lung Adenocarcinoma Based on Bioinformatics Technology.
Jia K, Ren X, Liu Y, Wang J
J Oncol. 2022; 2022:4339391.
PMID: 36090902
PMC: 9452934.
DOI: 10.1155/2022/4339391.
Prediction of Deleterious Single Nucleotide Polymorphism in S100A4 Metastatic Gene: Potential Early Diagnostic Marker.
Farhana A, Kothandan S, Alsrhani A, Mok P, Subbiah S, Khan Y
Contrast Media Mol Imaging. 2022; 2022:4202623.
PMID: 35965620
PMC: 9357733.
DOI: 10.1155/2022/4202623.
IFN-I inducible targets ADAR1 isoforms and fine tunes innate immune activation.
Vuillier F, Li Z, Black I, Cruciani M, Rubino E, Michel F
Front Immunol. 2022; 13:939907.
PMID: 35935998
PMC: 9354889.
DOI: 10.3389/fimmu.2022.939907.
Integrated analysis of the clinical consequence and associated gene expression of in -positive human cancers.
Saifullah , Tsukahara T
Heliyon. 2022; 8(7):e09878.
PMID: 35865984
PMC: 9293659.
DOI: 10.1016/j.heliyon.2022.e09878.
Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer.
Rui T, Xiang A, Guo J, Tang N, Lin X, Jin X
Front Mol Biosci. 2022; 9:818493.
PMID: 35655761
PMC: 9152170.
DOI: 10.3389/fmolb.2022.818493.
Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer.
Vittori C, Jeansonne D, Yousefi H, Faia C, Lin Z, Reiss K
Cancer Cell Int. 2022; 22(1):204.
PMID: 35642054
PMC: 9158314.
DOI: 10.1186/s12935-022-02620-z.
A novel information diffusion method based on network consistency for identifying disease related microRNAs.
Chen M, Peng Y, Li A, Li Z, Deng Y, Liu W
RSC Adv. 2022; 8(64):36675-36690.
PMID: 35558942
PMC: 9088870.
DOI: 10.1039/c8ra07519k.
ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.
Manco G, Lacerra G, Porzio E, Catara G
Biomolecules. 2022; 12(3).
PMID: 35327636
PMC: 8946771.
DOI: 10.3390/biom12030443.
Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention.
Arun R, Cahill H, Marcato P
Biomedicines. 2022; 10(3).
PMID: 35327452
PMC: 8945552.
DOI: 10.3390/biomedicines10030651.
MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?.
Cinque A, Capasso A, Vago R, Floris M, Lee M, Minnei R
Int J Mol Sci. 2022; 23(5).
PMID: 35269744
PMC: 8910117.
DOI: 10.3390/ijms23052602.
Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B.
He S, Guan S, Wu M, Li W, Xu M, Tao M
Transl Cancer Res. 2022; 8(8):2691-2703.
PMID: 35117027
PMC: 8798177.
DOI: 10.21037/tcr.2019.10.32.
miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer.
Li Y, Xun J, Wang B, Ma Y, Zhang L, Yang L
J Transl Med. 2021; 19(1):429.
PMID: 34656128
PMC: 8520297.
DOI: 10.1186/s12967-021-03102-y.
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.
Isca C, Piacentini F, Mastrolia I, Masciale V, Caggia F, Toss A
Cancers (Basel). 2021; 13(19).
PMID: 34638377
PMC: 8508299.
DOI: 10.3390/cancers13194894.
Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.
Rahmadi A, Fasyah I, Sudigyo D, Budiarto A, Mahesworo B, Hidayat A
Genes Genomics. 2021; 43(9):1079-1086.
PMID: 34152577
PMC: 8215323.
DOI: 10.1007/s13258-021-01119-7.